These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 711912)

  • 1. Serological evidence of presence of HBsAg undetectable by conventional radioimmunoassay in anti-HBc positive blood donors.
    Katchaki JN; Siem TH; Brouwer R
    J Clin Pathol; 1978 Sep; 31(9):837-9. PubMed ID: 711912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood donors positive for HBsAg and negative for anti-HBc antibody.
    Couroucé AM; Drouet J; LeMarrec N; Drouet A; Soulier JP
    Vox Sang; 1985; 49(1):26-33. PubMed ID: 4013141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B core antibody in volunteer blood donors: comparison of radioimmunoassay and indirect immunofluorescence.
    Katchaki JN; Siem TH; Brouwer R
    J Med Virol; 1979; 3(4):275-80. PubMed ID: 383904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved detection of hepatitis B surface antigen (HBsAg) in blood donors by monoclonal radioimmunoassay.
    Ben-Porath E; Wands JR; Bar-Shany S; Huggins C; Isselbacher K
    Transfusion; 1985; 25(1):10-4. PubMed ID: 3969695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
    Alizadeh Z; Milani S; Sharifi Z
    Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.
    Ye X; Li T; Xu X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Blood Transfus; 2017 Jan; 15(1):6-12. PubMed ID: 27416568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of occult hepatitis B virus infection among Omani blood donors: a preliminary study.
    Kaminski G; Alnaqdy A; Al-Belushi I; Nograles J; Al-Dhahry SH
    Med Princ Pract; 2006; 15(5):368-72. PubMed ID: 16888395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation.
    Olotu AA; Oyelese AO; Salawu L; Audu RA; Okwuraiwe AP; Aboderin AO
    Virol J; 2016 May; 13():76. PubMed ID: 27150469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of "anti-HBc alone" among Syrian blood donors.
    Muselmani W; Habbal W; Monem F
    J Infect Dev Ctries; 2014 Aug; 8(8):1013-5. PubMed ID: 25116667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors.
    Muselmani W; Habbal W; Monem F
    Transfus Med; 2013 Aug; 23(4):265-8. PubMed ID: 23621787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
    Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P
    Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult hepatitis B infections among blood donors in Lao PDR.
    Jutavijittum P; Andernach IE; Yousukh A; Samountry B; Samountry K; Thammavong T; Keokhamphue J; Toriyama K; Muller CP
    Vox Sang; 2014 Jan; 106(1):31-7. PubMed ID: 23931585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors.
    Karimi G; Zadsar M; Vafaei N; Sharifi Z; FalahTafti M
    Virol J; 2016 Mar; 13():36. PubMed ID: 26944046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of tests for HBeAg and anti-HBe in HBsAg positive blood donors.
    Dow BC; Macvarish I; Barr A; Crawford RJ; Mitchell R
    J Clin Pathol; 1980 Nov; 33(11):1106-9. PubMed ID: 7440758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
    Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of screening blood donors for antibody to hepatitis B core antigen.
    Archer AC; Cohen BJ; Mortimer PP
    J Clin Pathol; 1983 Aug; 36(8):924-8. PubMed ID: 6875019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-core antibody in HBsAg negative subjects].
    Ferroni P; Quartodipalo ME; Zanetti AR
    Boll Ist Sieroter Milan; 1978 Nov; 57(5):676-9. PubMed ID: 556542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.